Compare SVC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SVC | MDXG |
|---|---|---|
| Founded | 1995 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 839.2M | 672.8M |
| IPO Year | 1995 | 2007 |
| Metric | SVC | MDXG |
|---|---|---|
| Price | $6.15 | $4.45 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $12.19 | $7.40 |
| AVG Volume (30 Days) | ★ 2.5M | 1.1M |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | ★ 3.23% | N/A |
| EPS Growth | ★ 26.95 | 14.29 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,814,838,000.00 | $418,630,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.31 | $21.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.99 |
| 52 Week Low | $1.13 | $3.03 |
| 52 Week High | $9.02 | $7.97 |
| Indicator | SVC | MDXG |
|---|---|---|
| Relative Strength Index (RSI) | 43.34 | 39.79 |
| Support Level | $1.37 | $4.41 |
| Resistance Level | $6.87 | $4.48 |
| Average True Range (ATR) | 0.49 | 0.15 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 22.97 | 2.27 |
Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its segments hotel investment unit, and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza, Hyatt Place, and others.
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, the company sells allografts for ophthalmic surgery and dental applications through licenses to third parties.